Higginbottom; Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Higginbottom; Michael.The latest application filed is for "process for the preparation of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate".
Company Profile
6.21.40
- Higginbottom; Michael - Caldecote GB
- Higginbottom; Michael - Cambridge GB
- Higginbottom; Michael - London GB
- Higginbottom; Michael - Cambridgeshire GB
- Higginbottom; Michael - Highfields Caldecote GB
- Higginbottom, Michael - Sandwich DE
Patent Activity
| Patent | Date |
|---|---|
| Compounds I Grant 11,040,969 - Savory , et al. June 22, 2 | 2021-06-22 |
| CXCR4 receptor antagonists Grant 10,995,091 - Savory , et al. May 4, 2 | 2021-05-04 |
| Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylate Grant 10,988,473 - Horgan , et al. April 27, 2 | 2021-04-27 |
| Process For The Preparation Of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate App 20200062746 - HORGAN; Anne ; et al. | 2020-02-27 |
| Compounds I App 20190359611 - SAVORY; Edward ; et al. | 2019-11-28 |
| Compounds I Grant 10,399,973 - Savory , et al. Sep | 2019-09-03 |
| Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) Grant 10,316,034 - Savory , et al. | 2019-06-11 |
| Cxcr4 Receptor Antagonists App 20190062333 - SAVORY; Edward Daniel ; et al. | 2019-02-28 |
| CXCR4 receptor antagonists Grant 10,155,761 - Savory , et al. Dec | 2018-12-18 |
| New Compounds I App 20180118744 - SAVORY; Edward ; et al. | 2018-05-03 |
| Pharmaceutical Salt Forms Of An Inhibitor Of Semicarbazide-sensitive Amine Oxidase (ssao) App 20180111928 - SAVORY; Edward ; et al. | 2018-04-26 |
| Compounds I Grant 9,890,160 - Savory , et al. February 13, 2 | 2018-02-13 |
| CXCR4 Receptor Antagonists App 20170226106 - Savory; Edward Daniel ; et al. | 2017-08-10 |
| New Compounds I App 20170044157 - Savory; Edward ; et al. | 2017-02-16 |
| 4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds Grant 9,493,457 - Savory , et al. November 15, 2 | 2016-11-15 |
| Tonabersat Prodrugs App 20160318891 - Savory; Edward ; et al. | 2016-11-03 |
| CXCR4 receptor antagonists Grant 9,353,086 - Savory , et al. May 31, 2 | 2016-05-31 |
| CXCR4 Receptor Antagonists App 20160046606 - Savory; Edward Daniel ; et al. | 2016-02-18 |
| Inhibitor compounds of semicarbazide-sensitive amine oxidases Grant 9,227,967 - Evans , et al. January 5, 2 | 2016-01-05 |
| Enzyme inhibitor compounds Grant 9,150,574 - Evans , et al. October 6, 2 | 2015-10-06 |
| New Compounds I App 20150218161 - Savory; Edward ; et al. | 2015-08-06 |
| Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds Grant 9,035,066 - Savory , et al. May 19, 2 | 2015-05-19 |
| New Enzyme Inhibitor Compounds App 20140357623 - Evans; David ; et al. | 2014-12-04 |
| New Compounds I App 20140121219 - Savory; Edward ; et al. | 2014-05-01 |
| Protease Activated Receptor 2 (PAR2) Antagonists App 20130324556 - Boyd; Joe William ; et al. | 2013-12-05 |
| CXCR4 Receptor Antagonists App 20130289020 - Savory; Edward Daniel ; et al. | 2013-10-31 |
| Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds Grant 8,569,338 - Savory , et al. October 29, 2 | 2013-10-29 |
| 7-hydroxy-pyrazolo[1,5-a] Pyrimidine Compounds And Their Use As Ccr2 Receptor Antagonists App 20130252951 - Boyd; Joe William ; et al. | 2013-09-26 |
| New Enzyme Inhibitor Compounds App 20130102587 - Evans; David ; et al. | 2013-04-25 |
| New Compounds I App 20120302583 - Savory; Edward Daniel ; et al. | 2012-11-29 |
| 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds Grant 8,263,616 - Savory , et al. September 11, 2 | 2012-09-11 |
| Compounds useful for the treatment of conditions associated with weight gain Grant 8,093,248 - Boyd , et al. January 10, 2 | 2012-01-10 |
| New Compounds VII App 20110275670 - Chapman; Emma ; et al. | 2011-11-10 |
| Piperazine Derivatives And Their Use As Leptin Receptor Modulators App 20110275637 - Chapman; Emma ; et al. | 2011-11-10 |
| Piperazine Derivatives And Their Use As Leptin Receptor Modulators App 20110275638 - Chapman; Emma ; et al. | 2011-11-10 |
| New Pyridine Derivatives as Leptin Receptor Modulator Mimetics App 20110275678 - Higginbottom; Michael ; et al. | 2011-11-10 |
| New Compounds I App 20110207746 - Savory; Edward Daniel ; et al. | 2011-08-25 |
| Piperazines As Anti-obesity Agents App 20110059969 - Boyd; Joseph W. ; et al. | 2011-03-10 |
| New Compounds I App 20110046135 - Boyd; Joseph W. ; et al. | 2011-02-24 |
| Compounds I Grant 7,851,471 - Boyd , et al. December 14, 2 | 2010-12-14 |
| Therapeutic compounds Grant 7,807,685 - Higginbottom , et al. October 5, 2 | 2010-10-05 |
| Compounds II App 20090281087 - Boyd; Joseph W. ; et al. | 2009-11-12 |
| Compounds IV App 20090203695 - Higginbottom; Michael ; et al. | 2009-08-13 |
| New compounds I App 20090181967 - Boyd; Joseph W. ; et al. | 2009-07-16 |
| New compounds III App 20090176798 - Boyd; Joseph W. ; et al. | 2009-07-09 |
| Therapeutic compounds App 20080076776 - Higginbottom; Michael ; et al. | 2008-03-27 |
| Bombesin receptor antagonists App 20040116440 - Higginbottom, Michael ; et al. | 2004-06-17 |
| Bombesin receptor antagonists App 20040110768 - Higginbottom, Michael ; et al. | 2004-06-10 |
| Treatment of sexual dysfunction App 20040087561 - Gonzalez, Maria Isabel ; et al. | 2004-05-06 |
| Bombesin antagonists App 20040063643 - Higginbottom, Michael ; et al. | 2004-04-01 |
| NK1 receptor antagonists App 20030065007 - Creswell, Mark Wallace ; et al. | 2003-04-03 |
| Treatment of sexual dysfunction App 20020169101 - Gonzalez, Maria Isabel ; et al. | 2002-11-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 